Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

50 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Active, not recruiting

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Local Institution - 0002 Ahmedabad, Gujarat, India
  • Local Institution - 0001 New Delhi, National Capital Territory of Delhi, India
  • Local Institution - 0007 Kolkata, West Bengal, India
  • Local Institution - 0005 Assam, India
View Trial Details
Active, not recruiting

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

NCT06001385

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +37 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
View all 32 locations
View Trial Details
Active, not recruiting

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

NCT03165734

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • University of Alabama at Birmingham, (UAB) Hospital, Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 207 locations
View Trial Details
Active, not recruiting

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT04904588

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +30 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 39 locations
View Trial Details
Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 48 locations
View Trial Details
Completed

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

NCT02467270

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Indiana Blood & Marrow Transplantation Indianapolis, Indiana, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
  • Michigan Medicine Ann Arbor, Michigan, United States
View all 86 locations
View Trial Details
Completed

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

NCT03066648

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health Sciences University Main Center Portland, Oregon, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
View Trial Details

Related conditions